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Chapter 1. General Introduction 
 
1-1. Natural product chemistry 
 
   Natural products are organic compounds derived from living organisms. The vital activity of living organisms 
is regulated by natural products. By the study of natural products, their chemical structures and functions, and 
mechanisms of bioactivity are revealed. The study of natural product chemistry contributes to the development of 
healthcare as well as that of the chemistry. The chemotherapy, a treatment method using drugs, plays an important 
role in the medical treatment. In fact, a variety of natural products and their derivatives are used as drugs now. 
   For example, morphine, which was isolated from Papaver somniferum, is used as an analgesic drug (Figure 1). 
Benzylpenicillin, one of penicillins, was firstly isolated from the fungus Penicillium notatum, and is used as an 
antibiotic drug. Furthermore, Paclitaxel (taxol) was isolated from the stem bark of the western yew Taxus 
breuifolia.1) This compound is used as an antitumor drug.  
 
 
 
 
 
 
Figure 1. Structures of natural products used as drugs. 
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   As mentioned above, researchers have been investigated the bioactive substances derived from bacteria, 
animals, and plants, but search for new bioactive compounds is still required for the development of drug 
discovery. Since about a half-century ago, marine natural products have widely gotten a lot of attentions as the 
source of drugs, because marine organisms produce various secondary metabolites that have unique chemical 
structures and potent bioactivities. Up to the present time, a large number of marine natural products showing 
potent bioactivity have been reported. 
   For example, bryostatin-1 showing exceptionally potent antineoplastic activity was isolated from the bryozoan 
Bugula neritina (Figure 2). 2) Presently, clinic trials for anticancer and anti-Alzheimer's drugs have been 
conducted using bryostatin-1. The linear pentapeptide dolastatin 10 was isolated from the Indian Ocean sea hare 
Dolabella auricularia. 3) Dolastatin 10 also exhibits potent antineoplastic activity, and its derivative was approved 
for the treatment of Hodgkin’s lymphoma in 2011. 
 
 
 
 
 
Figure 2. Structures of marine natural products showing potent antineoplastic activity. 
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1-2. Aplysia kurodai 
 
   Sea hares belong to the opisthobranch group of mollusks. 4) They are shell-less and benthic marine 
invertebrates, and have been suggested to contain some kinds of chemical substances to defend themselves from 
predators. Among them, it is known that the genera Aplysia is rich sources of bioactive substances. 5) Up to the 
present time, a large number of secondary metabolites having potent and various bioactivities derived from the sea 
hare Aplysia kurodai have been reported, including aplyronine A, 6) pericosine A, 7) aplydilactone, 8) 
aplysiaterpenoid A 9) (Figure 3). Aplyronine A exhibits highly potent anti-tumor and actin-depolymerizing 
activities. Recently, aplyronine A was shown to induce protein–protein interactions between actin and tubulin and 
to prevent spindle formation and mitosis. 10) A shikimate derivative pericosine A shows significant growth 
inhibitory activity against human cancer cell lines. Moreover, this compound shows inhibitory effects against 
protein kinase EGFR and topoisomerase II. 11) Aplydilactone activates phospholipase A2, and aplysiaterpenoid A 
exhibits insecticidal activity. 
 
 
 
 
 
Figure 3. Structures of bioactive secondary metabolites isolated from Aplysia kurodai. 
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1-3. Anti-inflammatory activity 
 
   The cellular and vascular responses are occurred by tissue and cell damage such as pathogens and physical 
injuries. 12) These responses are called as inflammation (Figure 4). Inflammation causes the typical symptom(s) 
such as a rubor and edema. One of the causes of symptom is a free radical nitric oxide (NO) in phagocytes. The 
nuclear factor-kappa B (NF-κB), a nuclear transcription factor, is normally inactivated by the formation of 
complex with Inhibitor kappa B (IκB) in the cytoplasm. However, NF-κB activaion is induced by the secretion of 
substances such as inflammatory cytokines and endotoxin lipopolysaccharide (LPS) which are secreted by a series 
of stimuli. 13) Then activated NF-κB is translated into the nucleus, and inducible nitric oxide synthase (iNOS) 
mRNA is expressed by NF-κB. Translated iNOS mRNA are moved into the cytoplasm, and iNOS protein is 
expressed. Subsequently, inflammation occurs by the excess NO production by iNOS. 14) In this case, it is thought 
that this NO production inhibitory effect leads to the inhibition of inflammation. 15) 
   Thus, the author focused attention on the secondary metabolites derived from Aplysia kurodai as a source of 
anti-inflammatory substances. While a large number of potent and various bioactive substances have been isolated 
from A. kurodai, investigation of anti-inflammatory substances from A. kurodai have not been reported.  
   Based on these backgrounds, the author aimed to discover the novel compounds exhibiting NO production 
inhibitory activity and other bioactive substances from A. kurodai. 
 
 
 
 
 
Figure 4. One of the expression mechanisms of inflammation. 
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Chapter 2. Isolation and Structure Elucidation of 
 Aplysiasecosterols A, B, and C 
 
2-1. Introduction  
 
   As described in chapters 1, it is known that the sea hare Aplysia kurodai is rich sources of bioactive secondary 
metabolites. To our knowledge, however, investigation of anti-inflammatory substances from A. kurodai have not 
been reported. In our previous study, guided by the nitric oxide (NO) production inhibitory assay using 
LPS-stimulated murine macrophage RAW264.7 cells, 1) a cyclic heptapeptide stylissatin A that exhibits 
anti-inflammatory activity have been isolated from the Papua New Guinean marine sponge Stylissa massa (Figure 
5). 2) In the NO production inhibitory assay of cytotoxic compounds, NO production is reduced by decreased 
counts of cells. Thus, it is hard to evaluate the activity of cytotoxic compounds. Meanwhile, it is known that 
potent cytotoxic compounds such as aplyronin A are included in the A. kurodai extracts as shown in section 1-2. 
   For the above reason, if these cytotoxic compounds could be separated from the extracts, the 
anti-inflammatory substances might be purified from A. kurodai. 
 
 
 
 
Figure 5. Structure of stylissatin A. 
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2-2. NO production inhibitory assay 
 
   As described in section 1-3, within an organism, one of the causes for the inflammation is nitric oxide (NO) 
which were produced by iNOS excessively. In this case, inflammation could be suppressed by the inhibition of 
NO production effectively. 
   In the author’s laboratory, anti-inflammatory assay was conducted as follows. First, murine macrophage 
RAW264.7 cells were stimulated by an endotoxin LPS to upregulate NO production. After incubation of the cells 
with samples, the NO production inhibitory effect in cells was evaluated. Since NO is rapidly oxidized to stable 
nitrite (NO2–), NO production was indirectly evaluated by measuring the concentration of NO2– in the culture 
medium using Griess reagents (sulfanilamide and 1-naphthylethylenediamine). To evaluate the cytotoxicity of 
assay samples, MTT method was used to exclude cytotoxic compounds. Using this assay, investigation of novel 
compounds exhibiting NO production inhibitory activity from A. kurodai was carried out. 
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2-3. Isolation of aplysiasecosterols A, B, and C 
 
   In an effort to isolate new bioactive compounds, the sea hare Aplysia kurodai was collected from the coast of 
Shima peninsula, Mie Prefecture, Japan. 54.8 kg (wet weight) of sea hare was extracted with ethanol (EtOH) for 3 
days (Scheme 1). The EtOH extract was filtered, and the filtrate was concentrated. The residue was partitioned 
between ethyl acetate (EtOAc) and water. The EtOAc layer (103 g) was partitioned between 90% aq. methanol 
(MeOH) and n-hexane. The 90% aq. MeOH layer was partitioned between 60% aq. MeOH and dichloromethane 
(CH2Cl2) to obtain 16.1 g of the CH2Cl2 layer. 
 
 
 
 
 
 
Scheme 1. Isolation of aplysiasecosterols A, B, and C. 
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   The n-hexane layer was not active on the NO production inhibitory assay with LPS-stimulated murine 
macrophage RAW264.7 cells at 100 µg/mL. Concerning the 60% MeOH and CH2Cl2 layers, the activities could 
not be evaluated due to their cytotoxicity (IC50 < 100 µg/mL). Thus, the author decided to investigate the NO 
production inhibitory substance in the CH2Cl2 layer after the separation of cytotoxic constituents. The residue 
(16.1 g) was separated by a silica gel (SiO2) column chromatography (toluene/EtOAc/MeOH) to obtain five 
fractions (Fr. 1 to 5) (Scheme 2). In this column chromatography, the NO production inhibitory effect and 
cytotoxicity were successfully separated: Fr. 3 (toluene/EtOAc/MeOH = 0/4/1) showed the NO production 
inhibitory effect, and Fr. 1, 2, and 4 exhibited cytotoxicity. Fr. 3 (3.1 g) was further separated by SiO2 column 
chromatography (CHCl3/MeOH) to give five fractions (Fr. 1-1 to -5). Only Fr. 3-1 exhibited the NO production 
inhibitory activity. 
 
  
 
 
  
 
 
Scheme 2. Isolation of aplysiasecosterols A, B, and C. 
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   Fr. 3-1 (1.1 g) was fractionated by Sephadex LH-20 gel column chromatography (MeOH) to give 13 fractions 
(Fr. 3-1-1 to -13) (Scheme 3). Among them, Fr. 3-1-4 and -5 showed potent NO production inhibitory activity. 
 
 
 
 
 
 
 
 
 
Scheme 3. Isolation of aplysiasecosterols A, B, and C. 
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   Separation of Fr. 3-1-4 (670.9 mg) by SiO2 column chromatography (benzene/MeOH) provided six fractions 
(Fr. 3-1-4-1 to -6) (Scheme 4). Fr. 3-1-4-2, -3 and -4 exhibited the NO production inhibitory activity. Among 
these fractions, Fr. 3-1-4-3 (170.2 mg) was further separated by Al2O3 column chromatography 
(CHCl3/MeOH/AcOH) to give two fractions (Fr. 3-1-4-3-1 to -2). Fr. 3-1-4-3-1 eluted without AcOH showed NO 
production inhibitory activity at 100 µg/mL (Figure 6). 
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Scheme 4. Isolation of aplysiasecosterols A, B, and C. 
 
 
 
 
Figure 6. Effects of Fr. 3-1-4-3-1 and -2 on NO production in LPS-stimulated murine macrophage RAW264.7 
cells. NO production was indirectly evaluated by measuring the NO2– concentration in the culture media using 
Griess method. 1) MeOH and indomethacin were used as the negative and positive controls, respectively. 
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   Fr. 3-1-4-3-1 (75.5 mg) was separated by reverse-phase HPLC (Develosil ODS-HG-5, Φ20 × 250 mm, 50% 
MeOH, 5 mL/min, 215 nm, in three parts) to give six fractions (Fr. 3-1-4-3-1-1 to -6) (Scheme 5). Fr. 3-1-4-3-1-1 
(4.8 mg) was finally purified by reverse-phase HPLC (Develosil ODS-HG-5, Φ20 × 250 mm, 55% MeOH, 5 
mL/min, 254 nm) to afford aplysiasecosterol B (2) as a colorless oil (2.8 mg, 5.1 × 10–8 %, tR = 42.5 min). Fr. 
3-1-4-3-1-2 (3.0 mg) was purified by the same HPLC conditions to give aplysiasecosterol C (3) as a colorless oil 
(1.6 mg, 2.9 × 10–8 %, tR = 46.2 min). 
   Fr. 3-1-4-3-1-6 (64.0 mg) was fractionated by ODS silica gel column chromatography (MeOH/H2O) to give 
six fractions (Fr. 3-1-4-3-1-6-1 to -6). Among them, Fr. 3-1-4-3-1-6-2 (20.7 mg) included the component clearly 
separated by HPLC analysis. Then, Fr. 3-1-4-3-1-6-2 was separated by reverse-phase HPLC (Develosil 
ODS-HG-5, Φ20 × 250 mm, 60% MeOH, 5 mL/min, 215 nm) to obtain five fractions (Fr. 3-1-4-3-1-6-2-1 to -5). 
The major component of Fr. 3-1-4-3-1-6-2-4 (10.1 mg) was finally purified by reverse-phase HPLC (Develosil 
ODS-HG-5, Φ20 × 250 mm, 28% MeCN, 5 mL/min, 254 nm) to afford aplysiasecosterol A (1) as a colorless oil 
(6.7 mg, 1.2 × 10–7 %, tR = 65.3 min). 
   After the isolation of aplysiasecosterols A, B, and C (1, 2, and 3), the author investigated the NO production 
inhibitory activity of 16 remaining fractions (Fr. 3-1-4-3-1-3 to -5, Fr. 3-1-4-3-1-6-1, Fr. 3-1-4-3-1-6-3 to -6, Fr. 
3-1-4-3-1-6-2-1 to -3, Fr. 3-1-4-3-1-6-2-5, and Fr. 3-1-4-3-1-6-2-4-2 to -5). As a result, Fr. 3-1-4-3-1-6-3 and Fr. 
3-1-4-3-1-6-2-5 exhibited the NO production inhibitory activity. Therefore, the author will investigate other 
bioactive substances included in these two fractions in the future. 
 
 
 14 
 
 
Scheme 5. Isolation of aplysiasecosterols A, B, and C (1, 2, and 3). 
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2-4. Aplysiasecosterol A 
  2-4-1. Planar structure of aplysiasecosterol A 
 
   Aplysiasecosterol A (1) was isolated as a colorless oil. Based on the high resolution ESI-MS data ([M + Na]+, 
m/z 503.2979, Δ –0.6 mmu), the molecular formula of 1 was established to be C27H44O7 (Figure 8). The 1H 
(Figure 9) and 13C NMR (Figure 10), DEPT135 (Figure 11), and HSQC (Figure 14) spectra in CD3OD indicated 
the presence of the following signals: four singlet methyl groups (δH 0.89, 1.03, 1.12, 1.15), one doublet methyl 
group (δH 1.02), two oxymethine protons (δH 4.57, 3.22), one oxymethylene proton (δH 3.66), two carbonyl 
carbons (δC 220.2, 219.1), and one acetal carbon (δC 102.6) (Table 1). The IR (CHCl3) spectrum of 1 showed 
absorption bands for hydroxy group(s) (3568 cm–1) and two carbonyl groups (1736, 1708 cm–1). 
   A detailed analysis of the COSY (Figure 12) and double quantum filtered-COSY (DQF-COSY) (Figure 13) 
spectra of 1 allowed us to construct five partial structures: C-1–C-4, C-8–C-14–C-16, C-11–C-12, C-20–C-21, 
and C-23–C-24 (Figure 7). HMBC correlations between Me-19/C-1, C-6, C-9, and C-10 revealed that C-1, C-6, 
C-9, and C-19 were each connected to the sp3 quaternary carbon C-10. The C-4–C-5 connectivity and the 
presence of a tetrahydropyran ring in Partial Structure 1 were established based on HMBC correlations between 
H-3/C-5, C-6, and H-4/C-5. HMBC correlations between Me-18/C-12, C-13, and C-14 indicated that the C-8–
C-14–C-16 unit was linked to the C-11–C-12 unit via the sp3 quaternary carbon C-13. Further the C-8–C-9 
connectivity was provided by HMBC correlations between H-8 and H-14/C-9. HMBC correlations from Me-21 to 
C-17, C-20, and C-22 revealed that C-17, C-21, and C-22 were each connected to the sp3 methine carbon C-20 in 
Partial Structure 2. The connectivity between two single methyl groups (C-26, 27) and an 1,2-diol moiety was 
established by HMBC correlations between Me-26/C-24, C-25, and C-27, and Me-27/C-24, C-25, and C-26. For 
the above reason, two partial structures of 1 were provided to be as shown in Figure 7. 
   In the case of one- and two-dimensional NMR analysis in CD3OD, the C-7 methine signal was not observed. 
Furthermore, the author observed 27% decrease in the intensity of the H-4 proton signal located on the α-position 
of carbonyl group. In the ESI-MS data after the NMR measurement in CD3OD, intensity of an isotope peak m/z 
504.3 [M+1+Na]+ for 1 was observed about three times higher than the usual one. Therefore, it was suggested that 
the protons H-4 and H-7 were deuterated, and the carbon C-4 could not be determined to be methine or methylene 
carbon.  
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Figure 7. Partial structures of aplysiasecosterol A (1) based on the NMR analysis in CD3OD. 
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Table 1. NMR data for aplysiasecosterol A (1) in CD3OD 
 
 
 
 
 
 
 
 
 
13C NMRa) 1H NMRb, c) HMBC
δ (ppm), multiplicity δ (ppm), multiplicity, J [Hz] 1H   13C
1a 28.15 t 1.325 m C-3, 10, 19
1b 1.229 td (14.0, 5.0) C-3, 9, 10, 19
2a 25.0 t 1.96 tt (14.0, 5.0) C-1, 3, 4
2b 1.485 m
3 71.63 d 4.57 d (4.5) C-1, 4, 5, 6
4 44.5d) d? 2.36 br s C-3, 5
5 210.2 s
6 102.6 s
7
8 46.84 d 3.16 d (6.3) C-5, 6, 9, 13, 14
9 219.1 s
10 51.4 s
11 58.8 t 3.66 t (8.0) C-12, 13
12a 40.96 t 1.81 m C-11, 13, 14, 18
12b 1.715 m
13 47.5 s
14 50.87 d 2.014 ddd (11.1, 8.6, 6.3) C-9, 12, 18
15 25.69 t 1.705 m
16 26.27 t 1.37 m
17 50.37 d 1.487 m
18 17.54 q 0.89 s C-12, 13, 14
19 12.69 q 1.03 s C-1, 6, 9, 10
20 35.2 d 1.5 m
21 19.84 q 1.02 d (6.3) C-17, 20, 22
22a 33.39 t 1.508 m
22b 1.292 m
23a 29.42 t 1.517 m
23b 1.353 m
24 79.7 d 3.22 dd (10.14, 1.26) C-22, 23, 25, 27
25 73.9 s
26 24.88 q 1.12 s C-24, 25, 27
27 25.74 q 1.15 s C-24, 25, 26
d) The chemical shift was based on HMQC spectrum.The carbon C-4 could not be determined to be methine
    or methylene carbon. 
Atom No.
a) 13C NMR spectrum was measured at 150 MHz. Multiplicity was based on DEPT135 and HMQC spectra.
b) 1H NMR spectrum was measured at 600 MHz.
    lower-field signals were "b".
c) Coupling constants (Hz) are in parentheses. Lower-field methylene proton signals were labeled "a" and
 18 
 
Figure 8. ESI-MS spectrum of aplysiasecosterol A (1). 
 
 
Figure 9. 1H NMR spectrum of aplysiasecosterol A (1) in CD3OD (600 MHz). 
(m/z)
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Figure 10. 13C NMR spectrum of aplysiasecosterol A (1) in CD3OD (150 MHz). 
 
 
Figure 11. DEPT135 spectrum of aplysiasecosterol A (1) in CD3OD (150 MHz). 
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Figure 12. COSY spectrum of aplysiasecosterol A (1) in CD3OD (600 MHz). 
 
 
Figure 13. DQF-COSY spectrum of aplysiasecosterol A (1) in CD3OD (600 MHz). 
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Figure 14. HSQC spectrum of aplysiasecosterol A (1) in CD3OD (600 MHz). 
 
 
Figure 15. HMBC spectrum of aplysiasecosterol A (1) in CD3OD (600 MHz). 
 22 
   To prevent the deuteration and obtain additional structural information of 1, NMR spectra were measured in 
DMSO-d6 (Figure 17, 18, 19, 20, 21, and 22), (Table 2). Then the presence of methine carbon C-7 and methylene 
carbon C-4 were established. 
 In addition to the correlations established by COSY spectra in CD3OD, the H-7/H-8 and H-16/H-17 correlations 
were provided by COSY spectra in DMSO-d6 indicating connectivity between Partial structure 1 and 2 in Figure 7 
(Figure 16). 
   HMBC correlations between H-12a/C-14 and H-12b/C-17 indicated that C-12 and C-17 were each connected 
to the sp3 quaternary carbon C-13. HMBC correlation between H-4b/C-5 and C-7 exhibited that C-4 and C-7 were 
each connected to the carbonyl carbon C-5. Further HMBC correlations between H-7 and H-8/C-5, C-6, and C-9 
were also obseved. Based on the molecular formula and the degree of unsaturation, 1 was shown to contain four 
hydroxy groups at oxygenated carbons C-6, 11, 24, and 25. For the above reason, planar structure of 1 was 
determined to be either a γ-diketone structure (Proposed structure 1 in Figure 16) or a β-diketone structure 
(Proposed structure 2 in Figure 16). 
   While Proposed structure 1 had the C-6–C-7 and C-8–C-9 connectivities, Proposed structure 2 had the C-6–
C-8 and C-7–C-9 connectivities. Since important HMBC correlation between H-14/C-6 or C-9 was not observed, 
planar structure of 1 could not be determined to be either Proposed structure 1 or Proposed structure 2. 
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Figure 16. Proposed structures of aplysiasecosterol A (1) based on the NMR analysis in DMSO-d6. 
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Table 2. NMR data for aplysiasecosterol A (1) in DMSO-d6 
 
 
 
 
 
 
 
13C NMRa) 1H NMRb, c) HMBC
δ (ppm), multiplicity δ (ppm), multiplicity, J [Hz] 1H   13C
1a 26.38 t 1.24 m C-3, 6
1b 1.07 m C-9
2a 23.54 t 1.81 m C-3, 4
2b 1.45 m C-10
3 69.23 d 4.52 t (5.7) C-2, 4, 5, 6
4a 43.6 t 2.88 dd (16.3, 7.0) C-2, 3, 5
4b 2.32 d (16.3) C-2, 5, 7
5 208.37 s
6 100.96 s
7 61.71 d 2.74 br s C-5, 6, 8, 9, 14
8 44.75 d 2.97 dd (6.2, 1.5) C-5, 7, 9, 13, 14, 15
9 216.87 s
10 49.4 s
11a 56.41 t 3.53 td (10.4, 5.2) C-12, 13
11b 3.45 td (10.4, 5.2) C-12, 13
12a 39.85 t 1.63 m C-11, 13, 14, 18
12b 1.56 m C-11, 13, 17, 18
13 45.8 s
14 48.95 d 1.93 m C-7, 8, 15, 18
15a 24.19 t 1.6 m C-16
15b 1.34 m C-17
16a 24.91 t 1.59 m
16b 1.23 m
17 48.2 d 1.39 m
18 16.73 q 0.82 s C-12, 13, 14
19 12.43 q 0.92 s C-1, 6, 9, 10
20 33.57 d 1.4 m C-17
21 19.1 q 0.95 d (6.2) C-17, 20, 22
22a 31.93 t 1.35 m
22b 1.18 m
23a 27.79 t 1.43 m
23b 1.17 m C-24, 25
24 77.5 d 3.02 d (9.7) C-22, 23, 25, 26, 27
25 71.65 s
26 24.56 0.98 s C-24, 25, 27
27 26.3 q 1.03 s C-24, 25, 26
Atom No.
a) 13C NMR spectrum was measured at 150 MHz. Multiplicity was based on DEPT135 and HMQC spectra.
b) 1H NMR spectrum was measured at 600 MHz.
c) Coupling constants (Hz) are in parentheses. lower-field methylene proton signals were labeled "a" and
    lower-field signals were "b".
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Figure 17. 1H NMR spectrum of aplysiasecosterol A (1) in DMSO-d6 (600 MHz). 
 
 
Figure 18. 13C NMR spectrum of aplysiasecosterol A (1) in DMSO-d6 (150 MHz). 
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Figure 19. DEPT135 spectrum of aplysiasecosterol A (1) in DMSO-d6 (150 MHz). 
 
 
Figure 20. COSY spectrum of aplysiasecosterol A (1) in DMSO-d6 (600 MHz). 
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Figure 21. HSQC spectrum of aplysiasecosterol A (1) in DMSO-d6 (600 MHz). 
 
 
Figure 22. HMBC spectrum of aplysiasecosterol A (1) in DMSO-d6 (600 MHz). 
 28 
   To determine whether the planar structure of 1 was γ-diketone or β-diketone structure, the NMR spectra were 
measured in CDCl3 (Figure 24, 25, 26, 27, 28 and 29), (Table 3). HMBC correlation between H-14/C-9 was 
observed, indicating that C-8 was connected to the carbonyl carbon C-9. In addition to the connectivity provided 
previously, the C-15–C-16 and C-17–C-20–C-22 connectivities were confirmed by COSY spectra in CDCl3 
(Figure 23). Therefore, the planar structure of 1 was determined to be as shown in Figure 23. Futhermore, all of 
the protons and carbons were completely assigned on the NMR spectra measured in CDCl3. 
 
 
 
 
 
Figure 23. Planar structure of aplysiasecosterol A (1) based on the NMR analysis in CDCl3. 
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Table 3. NMR data for aplysiasecosterol A (1) in CDCl3 
 
 
13C NMRa) 1H NMRb, c) HMBC NOESY
δ (ppm), multiplicity δ (ppm), multiplicity, J [Hz] 1H   13C 1H 
1a 26.61 t 1.41 m
1b 1.25 m C-9, 10 H-4b, 8
2a 24.05 t 2.00 tt (14.0, 5.8) C-1 H-2b, 3, 19
2b 1.47 m H-2a, 3, 4b
3 70.25 d 4.62 t (5.8) C-1, 2, 5, 6 H-2a, 2b, 4a, 4b
4a 43.89 t 2.90 dd (16.5, 5.8) C-3, 5 H-3, 4b, 7
4b 2.40 d (16.5) C-5, 7 H-1b, 2b, 3, 4a
5 208.28 s
6 101.31 s
7 60.27 d 3.15 br s C-5, 6, 9, 10, 14 H-4a, 12b, 14
8 47.29 d 3.21 dd (8.7, 1.7) C-5, 6, 7, 9, 13, 14, 15 H-1b, 14, 18
9 216.50 s
10 50.08 s
11 58.99 t 3.80 m C-13 H-12b, 14, 21
12a 39.62 t 1.90 dt (16.0, 5.6) C-11, 13, 18 H-12a, 18, 21
12b 1.74 m C-11, 17 H-7, 11, 12a. 14
13 46.60 s
14 47.75 d 2.20 td (8.7, 8.7) C-8, 9, 13, 15 H-7, 8, 11, 12b
15 25.55 t 1.76 m C-16 H-16b
16a 24.77 t 1.75 m C-13 H-16b, 22a
16b 1.41 m H-15, 16b
17 49.30 d 1.52 m C-16 H-14, 21
18 17.02 q 0.89 s C-12, 13, 14, 17 H-8, 12a, 20
19 12.09 q 1.11 s C-1, 6, 9, 10 H-2a
20 33.03 d 1.44 m H-18, 21
21 19.92 q 0.92 d (6.6) C-17, 20, 22 H-11, 12a, 17, 22a, 22b
22a 31.96 t 1.49 m H-16a, 21
22b 1.27 m H-21
23 28.97 t 1.36 m C-24 H-24
24 78.64 d 3.33 d (9.0) H-23, 26
25 73.18 s
26 26.58 q 1.21 s C-24, 25, 27 H-24
27 23.22 q 1.15 s C-24, 25, 26
Atom No.
a) 13C NMR spectrum was measured at 150 MHz. Multiplicity was based on DEPT135 and HMQC spectra.
b) 1H NMR spectrum was measured at 600 MHz.
c) Coupling constants (Hz) are in parentheses. lower-field methylene proton signals were labeled "a" and lower-field signals were "b".
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Figure 24. 1H NMR spectrum of aplysiasecosterol A (1) in CDCl3 (600 MHz). 
 
 
Figure 25. 13C NMR spectrum of aplysiasecosterol A (1) in CDCl3 (150 MHz). 
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Figure 26. DEPT135 spectrum of aplysiasecosterol A (1) in CDCl3 (125 MHz). 
 
 
Figure 27. COSY spectrum of aplysiasecosterol A (1) in CDCl3 (600 MHz). 
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Figure 28. HSQC spectrum of aplysiasecosterol A (1) in CDCl3 (600 MHz). 
 
 
Figure 29. HMBC spectrum of aplysiasecosterol A (1) in CDCl3 (600 MHz). 
 33 
  2-4-2. Relative stereochemistry of aplysiasecosterol A 
 
   To determine the relative stereochemistry of the tricyclic γ-diketone structure of aplysiasecosterol A (1), 
coupling constant analysis and NOE experiments in CDCl3 were carried out. A H-2a at C-2 methylene carbon was 
observed as a triplet-triplet (J = 14.0, 5.8 Hz): the geminal coupling constant between H-2a and H-2b was 14.0 Hz, 
and the vicinal coupling constants between H-2a/H-1a, H-1b, and H-3 were 5.8, 14.0, and 5.8 Hz, respectively. 
Therefore H-1b and H-2a were oriented in an anti-arrangement in the tetrahydropyran ring (Figure 30a). Key 
NOEs were observed for H-1b/H-4b and H-1b/H-8, which indicated that these three protons faced each other on 
the concave face of the rigid tricyclic structure. Similarly, NOE correlations between H-4a/H-7 and H-2a/Me-19 
suggested that all of the protons H-2a, H-4a, H-7, and Me-19 were located in the convex face. Thus, H-1b, H-2a, 
and Me-19 were thought to be oriented in axial positions with respect to the tetrahydropyran ring in a chair 
conformation.  
   Furthermore, the observed small magnitudes of J2b,3 = ~0 Hz, J3,4b = ~0 Hz, and J7,8 = 1.7 Hz indicated that the 
dihedral angles for H-2b/H-3, H-3/H-4b, and H-7/H-8 were estimated to be close to 90°. 
   To confirm the relative stereochemistry of the tricyclic γ-diketone structure of 1, molecular modeling study 
was performed. Using a Merck molecular force field 94x (MMFF94x), the conformations of tricyclic γ-diketone 
model compound 4 were calculated. The substituent on C-8 was replaced with an isopropyl group. Model 
compound 4 had only one conformer within 7 kcal/mol of the lowest energy conformation. Geometry 
optimization with the density functional theory (DFT) method for 4 was conducted using the B3LYP/6-31G+ 
level of theory (Figure 30b). The calculated distances of H-1b/ H-4b, H-1b/H-8, H-2a/Me-19, and H-4a/H-7 for 4 
were 3.1, 2.9, 2.5, and 3.1 Å, respectively. Thus, this model satisfied all of the key NOEs observed for 1. The 
dihedral angles for H-2b/H-3, H-3/H-4b, and H-7/H-8 in _ were –67.8°, 72.3°, and 105.8°, respectively. Based on 
the Karplus equation, 3) the coupling constants of H-2b/H-3, H-3/H-4, and H-7/H-8 in 4 were estimated to be 0–2 
Hz, which coincided with those observed in 1 (ca. 0, 0 and 1.7 Hz, respectively). For the above reasons, the 
relative stereochemistry of the tricyclic γ-diketone portion of 1 was determined to be as shown for the model 
compound 4 in Figure 30a. 
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Figure 30. a) Relative stereochemistry of the tricyclic γ-diketone structure of 1 determined by one- and 
two-dimensional NMR analysis. b) Optimized structure of the tricyclic model compound 4 at the B3LYP/6-31G+ 
level of theory in the gas phase. The substituent on C-8 in 2 was replaced with an isopropyl group. Green arrows 
are the calculated distances between two selected protons. c) Newman projections with views along the C-2–C-3, 
C-3–C-4, and C-7–C-8 bonds in 4 illustrating the dihedral angles for H-2b/H-3, H-3/H-4b, and H-7/H-8, 
respectively. 
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Figure 31. NOESY spectrum of aplysiasecosterol A (1) in CDCl3 (600 MHz). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 36 
   To determine the relative stereochemistry of around the cyclopentane ring of 1, coupling constants analysis 
and NOE experiments in CDCl3 were performed (Figure 32). The pink and green arrows indicate the observed 
NOEs for the α- and β-oriented protons with respect to the cyclopentane ring, respectively. NOEs were observed 
for H-11a/H-14, H-12b/H-14, H-14/H-17, and Me-18/H-20 (Figure 32a). These data strongly suggested that H-12, 
H-14, and H-17 are oriented in one face (α-face), and Me-18 and H-20 are oriented in the opposite face (β-face) 
with respect to the cyclopentane ring. Furthermore, NOEs were observed for H-12a/Me-21, H-17/Me-21, 
H-16a/H-22a. These results suggested that Me-21 is oriented in the same face as H-12, and H-17 (α-face) with 
respect to the cyclopentane ring with C-20, as shown in Figure 32b. For above reasons, the relative 
stereochemistry of the cyclopentane ring part in 1 was established to be as shown in Figure 32. 
   The relative stereochemistry between the tricyclic structure and cyclopentane ring part in 1 was determined by 
a detailed NMR analysis. While the C-8(sp3)–C-14(sp3) bond is able to freely rotate, the large magnitude of J8,14 = 
8.7 Hz indicated that H-8 is positioned antiperiplanar to H-14. Based on the experiments described above, H-7 
and H-8 were found to be oriented in an anti-arrangement. NOEs were observed for H-7/H-14, H-7/H-12, and 
H-8/Me-18. These results suggested that H-7 is oriented in the same face as H-12, and H-14, and H-8 is oriented 
in the same face as H-18 with respect to the cyclopentane ring. Therefore, the relative stereochemistry of 1 except 
for the oxymethine carbon C-24 was determined to be as shown in Figure 32a.  
 
 
 
Figure 32. a) Relative stereochemistry around the cyclopentane ring of 1 determined by one- and 
two-dimensional NMR analysis. b) A Newman projection with a view along the C-20–C-17 bond. 
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   The relative stereochemistry of around the cyclopentane ring in 1 was confirmed by the comparison of the 13C 
NMR chemical shifts between 1 and related 9,11-secosterols 5 4), 6 5), and 7 6) (Figure 33). Among the 13C NMR 
chemical shifts of C-11–C-18 and C-20–C22, differences (Δδc (ppm) = δc (5 or 6 or 7) – δc (1)) of eight carbons 
(C-11–C-13 and C-16–C21) were less than 2.0 ppm. Differences of the chemical shifts of C-14, C-15, and C-22 
between 1 and three compounds were more than 2.0 ppm due to the difference of substituents. As a result, it was 
determined that the relative stereochemistry of the cyclopentane ring part in 1 was identical to those of typical 
9,11-secosteroids.  
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Figure 33.  Structures of representative 9,11-secosteroids and comparison of the 13C NMR chemical shifts with 1.  
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  2-4-3. Absolute stereochemistry of aplysiasecosterol A 
 
   To determine the absolute stereochemistry of aplysiasecosterol A (1), the experimental electronic circular 
dichroism (ECD) spectrum of 1 was compared with the calculated ECD data for the model compound 4 (Figure 
34). The ECD spectrum of 1 showed a negative first Cotton effect at λ = 312 nm (Δε –0.19) and a positive second 
Cotton effect at λ = 286 nm (Δε +0.22). The ECD spectrum for 4 was calculated at the PBEPBE/6-311G++(d,p) 
level of theory in implicit solvation model (CPCM 7), MeOH). This spectrum also had a negative ECD peak at λ = 
327 nm (Δε –3.3) and a positive ECD peak at λ = 277 nm (Δε + 5.0), which reproduced the signs of the 
experimental Cotton effects. As inferred from the molecular orbital analysis, the negative ECD band at λ = 324 
nm (band 2, Rvel –24.3) was mainly ascribed to the n→π* transition of the C-9 ketone (HOMO→LUMO+1; 
Figure 35). Meanwhile, slightly positive ECD bands at λ = 309 nm (band 3, Rvel +3.3) and λ = 299 nm (band 4, 
Rvel +7.4) were mainly ascribed to the n→π* transition of the C-5 ketone (HOMO-1→LUMO and HOMO-1→
LUMO + 1, respectively). In addition, the positive ECD band λ = 279 nm (band 6, Rvel +23.8) corresponded to the 
transition from HOMO-2 to LUMO+1. Other slightly ECD bands at λ = 349 nm (band 1, Rvel +6.3) and λ = 288 
nm (band 4, Rvel –10.2) were ascribed to the excited transition other than the n→π* transition of C-5 and C-9 
ketones. These bands were thought to be too weak to effect considerable influence on ECD spectrum. These 
results indicated that the absolute stereochemistry of the tricyclic γ-diketone part of 1 was identical to that of 4. 
Therefore the absolute stereochemistry of 1 except for the oxymethine carbon C-24 was determined. 
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Figure 34. a) Experimental ECD spectrum of 1 measured in MeOH at 0.73 mM. b) Calculated ECD data for the 
model compound 4 at the PBEPBE/6-311G++(d,p) level of theory in implicit solvent model (CPCM 7), MeOH), 
(solid line, left scale). Six first excited states for 4 were shown in solid bars (right scale). 
 
  
Figure 35. Molecular orbitals involved in the n→π* transition of the C-5 and C-9 ketones in 4. 
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   To determine the absolute configuration of the oxymethine carbon C-24 in 1, modified Mosher’s method 8) 
was attempted (Figure 36). Compound 1 was converted into 11,24-bis-(S)- and (R)-(MTPA) esters 8. By the 
comparison of the 1H NMR data of (S)- and (R)-11,24-(MTPA) esters 8, positive Δδ values were found for 
protons on the C-18–C-23 side, while negative Δδ values were found for protons on the C-25–C-27 side. Thus the 
absolute configuration of C-24 was determined to be R. For the above results, the absolute stereochemistry of 1 
was completely established. 
 
 
 
 
 
Figure 36. Δδ values (δS – δR) for the (S)- and (R)-11,24-bis-MTPA esters 8 prepared from 1 in Hz (600 MHz, 
CD3OD).  
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2-5. Aplysiasecosterols B and C 
  2-5-1. Planar structures of aplysiasecosterols B and C 
 
   Aplysiasecosterols B and C (2 and 3) were isolated as colorless oils. Based on the high resolution ESI-MS 
data ([M + Na]+, m/z 503.2965, Δ –1.4 mmu for 2 and m/z 503.2964, Δ –1.5 mmu for 3, respectively), the 
molecular formulae of 2 and 3 were established to be both C27H44O7, which was identical to that of 1 (Figure 39). 
The 1H (Figure 40), and 13C NMR (Figure 41), DEPT135 (Figure 42), and HSQC (Figure 44) spectra in CDCl3 in 
2 indicated the presence of the following signals: four singlet methyl groups (δH 0.70, 1.13, 1.17, 1.22), one 
doublet methyl group (δH 0.99), two oxymethine protons (δH 4.02, 3.33), two oxymethylene protons (δH  3.86, 
3.72), one vinyl proton (δH 6.68), and two carbonyl carbons (δC 201.9, 200.8) (Table 5). The IR (CHCl3) spectrum 
of 2 showed absorption bands for hydroxy group(s) (3567 cm–1) and unsaturated carbonyl group(s) (1681 cm–1). 
   A detailed analysis of the COSY spectrum of 2 allowed the author to construct three partial structures: C-1–
C-4, C-7–C-8–C-14–C-17–C-20–C-24, and C-11–C-12 (Figure 37). HMBC correlations between Me-19/C-1, C-5, 
C-9, and C-10 revealed that C-1, C-5, C-9, and C-19 were each connected to the sp3 quaternary carbon C-10. The 
C-8–C-9 connectivity was established based on HMBC correlations between H-7/C-9 and H-14/C-9. Furthermore, 
HMBC correlations between H-4 and H-7/C-5, 5-OH/C-6, and H-4/C-10 established an α-hydroxy unsaturated 
ketone structure at C-6. These results indicated that 2 has a bicyclic conjugated-1,4-diketones structure that 
corresponds to a typical steroid AB ring. Furthermore, HMBC correlations between Me-18/C-12, C-13, C-14, and 
C-17 revealed that the C-7–C-8–C-14–C-17–C-20–C-24 unit was linked to the C-11–C-12 unit via the sp3 
quaternary carbon C-13. The connectivity between two singlet methyl groups (C-26, 27) and an 1,2-diol moiety 
was established by HMBC correlations between Me-26/C-24, C-25, and C-27, and Me-27/C-24, C-25, and C-26. 
Based on the molecular formula and the degree of unsaturation, 2 was shown to contain five hydroxy groups at 
C-3, 5, 11, 24, and 25. For the above reason, the planar structure of aplysiasecosterol B (2) was determined to be 
as shown in Figure 37. Furthermore, all of the protons and carbons were completely assigned on the NMR spectra 
measured in CDCl3. 
   Based on the one- and two-dimensional NMR analysis in CDCl3 (Figure47, 48, 49, 50, 51, and 52), the planar 
structure of aplysiasecosterol C (3) was also determined to be as shown in Figure 38, and all of the protons and 
carbons were completely assigned on the NMR spectra measured in CDCl3. 
   The planar structure of 3 was identical to that of 2. Furthermore, the 1H and 13C NMR signals in 3 were almost 
the same as those in 2, except for the oxymethine proton H-24. Therefore, The author estimated that 2 and 3 were 
the C-24 diastereomers.   
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Figure 37. Planar structure of aplysiasecosterol B (2) based on the NMR analysis in CDCl3. 
 
 
 
 
 
Figure 38. Planar structure of aplysiasecosterol C (3) based on the NMR analysis in CDCl3. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
COSY
HMBC
8
12
11
2018
17
16
15
14
13
24
23
2221
26
25
27
HO
OH
OH
O
O
HO
HO
7
9
191
2
3
4
5 6
10
COSY
HMBC
8
12
11
2018
17
16
15
14
13
24
23
2221
26
25
27
HO
OH
OH
O
O
HO
HO
7
9
191
2
3
4
5 6
10
 44 
Table 4. NMR data for aplysiasecosterol B (2) in CDCl3 
 
 
a) 13C NMR spectrum was measured at 150 MHz. Multiplicity was based on HMQC spectra.  
b) 1H NMR was measured at 600 MHz.  
c) Coupling constants (Hz) are in parenthesis. Lower-field methylene signals were labeled as “a” and higher-field signals as “b”.  
ND: not determined.  
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Table 5. NMR data for aplysiasecosterol C (3) in CDCl3 
 
 
a) 13C NMR spectrum was measured at 150 MHz. Multiplicity was based on HMQC spectra.  
b) 1H NMR was measured at 600 MHz.  
c) Coupling constants (Hz) are in parenthesis. Lower-field methylene signals were labeled as “a” and higher-field signals as “b”.  
ND: not determined.  
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Figure 39. ESI-MS spectrum of aplysiasecosterol B (2). 
 
 
Figure 40. 1H NMR spectrum of aplysiasecosterol B (2) in CDCl3 (600 MHz). 
(m/z)
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Figure 41. 13C NMR spectrum of aplysiasecosterol B (2) in CDCl3 (150 MHz). 
 
 
Figure 42. DEPT135 spectrum of aplysiasecosterol B (2) in CDCl3 (125 MHz). 
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Figure 43. COSY spectrum of aplysiasecosterol B (2) in CDCl3 (600 MHz). 
 
 
Figure 44. HSQC spectrum of aplysiasecosterol B (2) in CDCl3 (600 MHz). 
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Figure 45. HMBC spectrum of aplysiasecosterol B (2) in CDCl3 (600 MHz). 
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Figure 46. ESI-MS spectrum of aplysiasecosterol C (3). 
 
 
Figure 47. 1H NMR spectrum of aplysiasecosterol C (3) in CDCl3 (600 MHz). 
(m/z)
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Figure 48. 13C NMR spectrum of aplysiasecosterol C (3) in CDCl3 (150 MHz). 
 
 
Figure 49. DEPT135 spectrum of aplysiasecosterol C (3) in CDCl3 (125 MHz). 
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Figure 50. COSY spectrum of aplysiasecosterol C (3) in CDCl3 (600 MHz). 
 
 
Figure 51. HSQC spectrum of aplysiasecosterol C (3) in CDCl3 (600 MHz). 
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Figure 52. HMBC spectrum of aplysiasecosterol C (3) in CDCl3 (600 MHz). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 54 
  2-5-2. Relative stereochemistry of aplysiasecosterols B and C 
 
   To determine the relative stereochemistry around the cyclopentane ring of 2, ROE experiments in CDCl3 were 
performed (Figure 53). The pink and green arrows show the observed ROEs for the α- and β-oriented protons 
with respect to the cyclopentane ring, respectively. ROEs were observed for H-11a/H-14, H-11b/H-14, 
H-12a/H-14, H-14/H-17, and Me-18/H-20 (Figure 53a). These data strongly suggested that H-12, H-14, and H-17 
were oriented in one face (α-face), and Me-18 and H-20 were oriented in the opposite face (β-face) with respect 
to the cyclopentane ring. Furthermore, ROEs were observed for H-12a/Me-21, H-17/Me-21, H-17/H-22a. These 
results suggested that Me-21 is oriented in the same face as H-12, and H-17 (α-face) with respect to the 
cyclopentane ring with C-20, as shown in Figure 53b. For above reasons, the relative stereochemistry of the 
cyclopentane ring part in 2 was established to be as shown in Figure 53. 
   For aplysiasecosterol C (3), the observed ROEs were almost the same as those described above for 2. 
Furthermore, the 1H and 13C NMR signals in 3 were almost the same as those in 2, except for the oxymethine 
proton H-24. Therefore, The author determined the relative stereochemistry of the cyclopentane ring part in 3, 
which was identical to that in 2. 
 
 
 
 
 
Figure 53. a) Relative stereochemistry around the cyclopentane ring of 2 determined by one- and 
two-dimensional NMR analysis. b) A Newman projection with a view along the C-20–C-17 bond. 
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Figure 54. ROESY spectrum of aplysiasecosterol B (2) in CDCl3 (600 MHz). 
 
 
Figure 55. ROESY spectrum of aplysiasecosterol C (3) in CDCl3 (600 MHz). 
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   To confirm the relative stereochemistry around the cyclopentane ring in 2 and 3, their 13C NMR chemical 
shifts were compared with those of 2, 3, and 1 (Figure 56). Among the 13C NMR chemical shifts of C-11–C-18 
and C-20–C22, differences (Δδc (ppm) = δc (2 or 3) – δc (1)) of ten carbons (C-11–C-13, C-15–C-18, and C-20–
C-22) except for C-14 were less than 1.9 ppm. Differences of the chemical shift of C-14 were 4.0 ppm due to the 
difference of substituents. Thus, the relative stereochemistry of the cyclopentane ring part in 2 and 3 were 
identical to those of 1. For above reason, it was determined that the relative stereochemistry of the cyclopentane 
ring part in 2 and 3 were identical to those of 1 and typical 9,11-secosteroids. 
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Figure 56.  Structures of 1, 2, and 3, and comparison of the 13C NMR chemical shifts. 
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   The relative stereochemistry of the cyclohexane ring part for 2 and 3 were established by following processes. 
The coupling constants of H-3 (dtt, J = 9.1, 2.6, 2.6 Hz) and 3-OH (d, J = 9.1 Hz) in both 2 and 3 suggested that 
H-3 was oriented in an equatorial position with respect to the cyclohexane ring with a chair conformation. 
However, the author could not obtain enough NMR data (coupling constants and ROEs) to determine the The 
relative stereochemistry of the cyclohexane ring part for 2 and 3 unequivocally. 
   MTPA esters were prepared from 2 and 3 to determined the stereochemistry of C-24. Compound 2 was once 
converted into 3,11,24-tris-(S) and (R)-MTPA esters 9 as analytically pure form (Scheme 6), (Figure 57). One 
hour after the purification of 9, however, 9 and 11,24-bis-(S) and (R)-MTPA esters 10 were observed as a mixture 
by HPLC and ESI-MS analysis. Furthermore, 9 was completely converted into 10 even at –30 °C for less than one 
week. 11,24-bis-(S) and (R)-MTPA esters of 3 were similarly prepared via 3,11,24-tris-(S) and (R)-MTPA esters. 
This result strongly suggested that the C-3 ester moiety of 9 was selectively hydrolyzed based on the presence of 
neighboring group participation of the C-5 tertiary alcohol moiety via strong hydrogen bonding (Figure 58). Thus, 
the hydroxy groups 3-OH and 5-OH in 2 and 3 were assumed to be cis and in a 1,3-diaxial arrangement with 
respect to the cyclohexane ring, and the relative stereochemistry of the cyclohexane ring part for 2 and 3 were 
refined to either 5,10-cis- or 5,10-trans-fused structures shown in Figure 58. 
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Scheme 6. Preparation of the MTPA esters of 2 and their degradation. 
 
 
 
Figure 57. HPLC analysis of tris- and bis-(R)-MTPA esters 9 and 10 prepared from 3. 
 
 
Figure 58. Proposed relative structures of tris-MTPA ester in 2 and 3. 
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   To confirm that the hydroxy groups 3-OH and 5-OH in 2 and 3 were in a 1,3-diaxial arrangement with respect 
to the cyclohexane ring, acetonide protection of triol 10 with 2-methoxypropene was tried. As a result, the 
reaction gave acetonide 11 detected by LC-MS analysis (Scheme 7). Thus, both 3-OH and 5-OH could be 
confirmed to be oriented in axial positions concerning the the cyclohexane ring with a syn-arrangement. 
 
 
 
 
 
Scheme 7. Preparation of acetonide 11 from 11,24-bis-MTPA ester 10. 
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   To determine whether 2 and 3 have cis- or trans-fused conjugated-1,4-diketone structures, molecular 
modeling study was performed. Using a Merck molecular force field 94x (MMFF94x) in an implicit solvation 
model (CHCl3), the molecular structures of model compounds 12 (5,10-cis-fused) and 13 (5,10-trans-fused) were 
calculated and shown in Figure 59. The substituents on C-8 were replaced with a methyl group. Model compound 
12 had two conformers (i) and (ii), while 13 had only one conformer (iii) within 7 kcal/mol of the lowest energy 
conformation. Geometry optimization with the density functional theory (DFT) method for these three conformers 
was conducted using the B3LYP/6-31G+(d,p) level of theory in implicit solvation model (CPCM 7), CHCl3). Then, 
the cis-fused 3,5-diaxial conformer (i) was lower in energy by 4.7 kcal/mol than the 3,5-diequatorial conformer 
(ii). This high stability of conformer (i) might be due to the hydrogen bonding among the hydroxy groups 3-OH, 
5-OH, and the carbonyl group C-6. The calculated distances of H-1a/Me-19, H-1b/Me-19, H- 2a/H-3, H-3/H-4b, 
and 5-OH/Me-19 in conformer (i) were 2.4–3.1 Å. Thus, this model satisfied all of the key ROEs observed for 
both 2 and 3. Meanwhile, in conformer (iii), H-1b and 5-OH were positioned antiperiplanar to Me-19, which did 
not match the observed ROE correlations. The protons H-2b, H-4b, and Me-19 in conformers (iii) were in a 
1,3-diaxial arrangement with respect to each other, and their calculated distances were less than 2.8 Å. However, 
the ROE correlations between H-2b/Me-19 and H-4b/Me-19 were not observed in the natural compounds. Due to 
the close chemical shifts, the author could not observe the long-range (W-shape) coupling of H-2a/H-4a or the 
ROE correlation between H-2b/H-4b. In the plausible conformer (i), the dihedral angles for H-3/H-2a, H-2b, H-4a, 
and H-4b were 49.9–66.1°. Based on the Karplus equation 3), the coupling constants of H-3/H-2a, H-2b, H-4a, and 
H-4b were estimated to be relatively small magnitudes as gauche arrangements, which coincided with those 
observed in both 2 and 3 (ca. 2.6 Hz). For the above reason, the relative stereochemistry of the cyclohexane ring 
part for natural 2 and 3 was elucidated to be as shown in the conformer (i) of 5,10-cis-fused 
3β,5β-dihydroxy-conjugated-1,4-diketone 12 in Figure 59.  
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Figure 59. Structures of the 5,10-cis-fused 3β,5β-dihydroxy- and 5,10-trans-fused 3α,5α-dihydroxy-conjugated- 
1,4-diketone 12 and 13 and their optimized structures at the B3LYP/6-31G+(d,p) level of theory in implicit 
solvation model (CPCM 7), CHCl3). The relative energy of conformers (i) and (ii) is shown below. Observed and 
unobserved ROEs in aplysiasecosterol B (2) are shown as solid and dashed pink arrows, respectively. Values 
represent the calculated distances between two selected protons in Å. 
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   Recently, two 9,11-secosteroids that are structurally-related to 2 and 3 were isolated from the Korean marine 
sponge Ircinia sp., which have a 5,10-trans-fused 3β,5α-dihydroxy-conjugated-1,4-diketone structure. 4, 9) As 
noted by Yang et al., 13C NMR data for the 5,10-trans-fused 3β,5α-dihydroxy 9,11-secosteroids 5 and 14 (δC3 
66.6 and δC5 80.5) were close to those of a 5,10-trans-fused 3β,5α-dihydroxy-6-one steroid derivative 15 (δC3 
66.8 and δC5 80.3) 10). Similarly, 13C NMR data for 2 and 3 (δC3 65.1 and δC5 81.0) coincided with those for a 
5,10-cis-fused 3β,5β-dihydroxy-6-one steroid derivative 16 (δC3 65.5 and δC5 81.9) 10), rather than a 5α isomer. 
Thus, the relative stereochemistry of the cyclohexane ring part for natural 2 and 3 was confirmed thought to be as 
shown in Figure 60. 
 
 
 
 
 
Figure 60.  Structures of 2 and related 3β,5α- and 3β,5β-dihydroxy-6-one steroid derivatives. Values in blue 
represent the 13C NMR chemical shifts in ppm. 
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  2-5-3. Absolute stereochemistry of aplysiasecosterols B and C 
 
   To determine the absolute configuration of the oxymethine carbons C-24 in aplysiasecosterols B (2) and C (3), 
modified Mosher’s method 8) was attempted. For compound 2, by the comparison of the 1H NMR data of 
11,24-bis-(S)- and (R)-(MTPA) esters 10, positive Δδ values were found for protons on the C-18–C-23 side, while 
negative Δδ values were found for protons on the C-25–C-27 side (Figure 61). Thus the absolute configuration of 
C-24 in 2 was determined to be R. Similarly, the opposite Δδ patterns established that the absolute configuration 
of C-24 in 3 was determined to be S. 
 
 
 
 
Figure 61. Δδ values (δS – δR) for the (S)- and (R)-11,24-bis-MTPA esters 10 prepared from a) 2 and b) 3 in Hz 
(600 MHz, CD3OD). 
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   In general, it is known that 9,11-secosteroids are afforded by the oxidative cleavage of C-9–C-11 bond of 
precursor steroid. A number of steroids and 9,11-secosteroids have been isolated from nature. Furthermore, these 
steroids has typical steroidal skeleton as shown in Figure62, its enantiomer are not found in nature. Thus, based on 
the high structural similarities among 2, 3, and typical steroids, the absolute configuration of C-19 methyl and the 
cyclopentane ring part were estimated to be identical to those of typical steroids. Therefore, the absolute 
stereochemistry of 2 and 3 was determined to be as shown in Figure 63. 
 
 
 
 
 
 
Figure 62. The absolute stereochemistry of general steroidal skeleton. 
 
 
 
 
 
 Figure 63. The absolute stereochemistry of 2 and 3. 
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2-6. Proposed biosynthetic pathway of aplysiasecosterol A 
 
   The structure of the cyclopentane ring and the side-chain part of 1 was similar to those of known 
9,11-secosteroids. However, 1 did not have the structure corresponding to the AB-rings system of typical steroids, 
but an unprecedented tricyclic γ-diketone structure. Furthermore, 1 and 2 were isolated from the same marine 
organism, and the structure of the D-ring and the side-chain part of 9,11-secosteroid 2 was identical to those of 1. 
Therefore, 2 was assumed to be a biosynthetic precursor of 1. Then, the author proposed a biosynthetic pathway 
for the tricyclic γ-diketone structure of 1 starting from 2, as shown in Scheme 8. The α-ketol rearrangement 11) in 
2 would lead to the formation of the C-6–C-10 bond to give the α,β-unsaturated ketone 17. The vinylogous 
α-ketol rearrangement in 17 might form the C-5–C-7 bond, to afford the bicyclic diketone 18. Finally, protonation 
at C-8 on the concave face and intramolecular acetalization at the C-6 ketone in 18 would afford the tricyclic 
γ-diketone structure of 1. The stereochemistry of the methine carbon at C-8 in general steroids is opposite to that 
in 1. However, protonation at C-8 in 18 might occur to give priority to the thermodynamically stable 
exo-substituent 8S isomer. 
 
 
 
 
 
 
Scheme 8. Proposed biosynthetic pathway for the tricyclic γ-diketone structure of 1. 
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2-7. Bioassay 
  2-7-1. iNOS assay 
 
   The author investigated the NO production inhibitory activity against LPS-stimulated murine macrophage 
RAW264.7 cells of aplysiasecosterols A, B, and C (1, 2, and 3) (Figure 64). 1) As a result, 1, 2, and 3 did not show 
significant NO production inhibitory activity at 100 µM. Thus, it seems that other compounds in the sea hare 
extracts might inhibit NO production in RAW264.7 cell. 
 
 
 
 
Figure 64. Effects of 1, 2, and 3 on NO production in LPS-stimulated murine macrophage RAW264.7 cells. NO 
production was indirectly evaluated by measuring the NO2– concentration in the culture media using Griess 
method. 1) MeOH and indomethacin were used as the negative and positive controls, respectively. 
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  2-7-2. Cytotoxicity 
 
  Then, the author investigated the cytotoxicity of the 1, 2, and 3 against the human cervical carcinoma cell line 
HeLa S3 and the human myelomonocytic leukemia cell line HL-60 (Figure 65). Compound 1, 2, and 3 did not 
show considerable cytotoxicity against HeLa S3 cells at 200 µM. Furthermore, 2 and 3 did not show considerable 
cytotoxicity against HL-60 cells at 50 µM. However, 1 exhibited moderate cytotoxicity against HL-60 cells (IC50 
16 µM). Therefore, the tricyclic γ-diketone structure of 1 was suggested to be important for its cytotoxicity. 
 
 
 
 
 
 
 
Figure 65. Cytotoxicity of the 1, 2, and 3 against HeLa S3 and HL-60 cells. 
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2-8. Experimental 
 
General Methods. 
   1D and 2D NMR spectra were recorded on a Bruker AVANCE 600 (600 MHz for 1H NMR and 150 MHz for 
13C NMR) spectrometer or a Bruker AVANCE 500 (125 MHz for 13C NMR) spectrometer using Shigemi 
symmetrical NMR microtubes (Cat. Nos. DMS-005TB, CMS-005TB, and MMS-005TB). Chemical shifts were 
recorded in parts per million (ppm) relative to the residual solvent peaks at δH 7.26 and δC 77.0 in CDCl3, δH 2.50 
and δC 39.5 in DMSO-d6, and δH 3.30 and δC 49.0 in CD3OD, and coupling constants are shown in hertz (Hz). 
The following abbreviations are used for spin multiplicity: s = singlet, d = doublet, t = triplet, q = quartet, m = 
multiplet, and br = broad. The IR spectra were recorded on a JASCO FT/IR-4100 instrument and were shown in 
wavenumbers (cm−1). ESI mass spectra were recorded on a JEOL AccuTOF-CS spectrometer. Optical rotations 
were recorded on a JASCO DIP-1000 polarimeter using the sodium D line. LC-MS analysis was performed by 
using a Shimadzu LCMS-2020 spectrometer equipped with the Prominence LC-20A HPLC system. The 
electronic circular dichroism (ECD) spectrum was recorded on a JASCO J-820 spectropolarimeter. Fuji Silysia 
silica gel BW-820MH, E. Merck aluminum oxide, and Nacalai Tesque ODS silica gel Cosmosil 75C18-OPN were 
used for column chromatography. Chemicals and solvents were obtained from commercial sources. Solvents for 
reverse-phase HPLC were purchase as HPLC grade. 
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Isolation of aplysiasecosterols A, B, and C (1, 2, and 3). 
   The sea hare Aplysia kurodai was collected off the coast of Shima peninsula, Mie Prefecture, Japan. 54.8 kg 
(wet weight) of sea hare was immersed in ethanol (86 L) for 3 days. The ethanol extract was filtered, and the 
filtrate was concentrated. The residue was partitioned between ethyl acetate (3 × 1 L) and water (1 L). The ethyl 
acetate layer was concentrated. The residue (103 g) was partitioned between 90% methanol (1 L) and hexane (4 × 
1 L). The 90% methanol layer was concentrated and partitioned between 60% methanol (1 L) and 
dichloromethane (4 × 1 L). The dichloromethane layer was concentrated. The residue (16.1 g) was loaded on a 
silica gel column (300 g) and eluted with toluene/EtOAc/MeOH = 1/1/0 → 0/1/0 → 0/4/1 → 0/1/1 → 0/0/1 (1.8 L 
each) to obtain five fractions (Fr. 1 to 5). Fr. 3 (3.1 g) was loaded on a silica gel column (50 g) and eluted with 
CHCl3/MeOH = 19/1 → 9/1 → 4/1 → 1/1 → 0/1 (300 mL each) to give five fractions (Fr. 3-1 to -5). Fr. 3-1 (1.1 
g) was loaded on a Sephadex LH-20 gel column (400 g) and eluted with methanol (400 mL) to obtain 13 fractions 
(Fr. 3-1-1 to -13). Fr. 3-1-4 (670.4 mg) was loaded on a silica gel column (25 g) and eluted with CHCl3/MeOH = 
19/1 → 9/1 → 4/1 → 1/1 → 0/1 (150 mL each) to give six fractions (Fr. 3-1-4-1 to -6). Fr. 3-1-4-3 (170.2 mg) 
was loaded on an aluminum oxide column (20 g) and eluted with CHCl3/MeOH/AcOH = 4/1/0 → 1/1/0 → 0/1/0 
→ 0/4/1 → 0/1/1 (60 mL each) to obtain two fractions (Fr. 3-1-4-3-1 and -2). Fr. 3-1-4-3-1 (75.5 mg) was 
separated by reverse-phase HPLC (Develosil ODS-HG-5, Φ20 × 250 mm, 50% aqueous methanol, 5 mL/min, 
215 nm) in three parts to give six fractions (Fr. 3-1-4-3-1-1 to -6). Fr. 3-1-4-3-1-3 (4.8 mg) was finally purified by 
reverse-phase HPLC (Develosil ODS-HG-5, Φ20 × 250 mm, 55% aqueous methanol, 5 mL/min, 254 nm) to 
afford aplysiasecosterol B (2) (2.8 mg, 5.1 × 10–8 %, tR = 42.5 min). Fr. 3-1-4-3-1-4 (3.0 mg) was purified by the 
same HPLC conditions to give aplysiasecosterol C (3) (1.6 mg, 2.9 × 10–8 %, tR = 46.2 min).  
   Fr. 3-1-4-3-1-6 (64.0 mg) was loaded on an ODS silica gel column (Cosmosil 75C18-OPN, 5 g) and eluted 
with 60, 70, 80, 90, and 100% aqueous methanol (15 mL each) to obtain six fractions (Fr. 3-1-4-3-1-6-1 to -6). Fr. 
3-1-4-3-1-6-2 (20.7 mg) was separated by reverse-phase HPLC (Develosil ODS-HG-5, Φ20 × 250 mm, 60% 
aqueous methanol, 5 mL/min, 215 nm) to give five fractions (Fr. 3-1-4-3-1-6-2-1 to -5). Fr. 3-1-4-3-1-6-2-4 (10.1 
mg) was applied to a Develosil ODS-HG-5 reversed-phase HPLC column (Φ20 × 250 mm). The sample was 
eluted with 28% aqueous acetonitrile at a flow rate of 5 mL/min, with monitoring at 254 nm, to afford 
aplysiasecosterol A (1) (6.7 mg, 1.2 × 10–7 %, tR = 65.3 min). 
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Aplysiasecosterol A (1): a colorless oil; [α]24D +19.3 (c 0.228, MeOH); IR (CHCl3) 3568 (br), 2958, 2873, 1736, 
1708, 1469, 1375, 1243, 1217, 1166, 1072, 739 cm–1; 1H and 13C NMR data, see Table 1, 2, and 3; HR-ESIMS 
m/z 503.2979 [M+Na]+ (calcd for C27H44NaO7, Δ –0.6 mmu). 
 
Aplysiasecosterol B (2): a colorless oil; [α]27D +20 (c 0.073, MeOH); IR (CHCl3) 3691, 3567 (br), 3027, 2952, 
1681, 1603, 1457, 1291, 1212, 1147, 998, 829 cm–1; 1H and 13C NMR data, see Table 4; HR-ESIMS m/z 503.2965 
[M+Na]+ (calcd for C27H44NaO7, Δ –1.4 mmu). 
 
Aplysiasecosterol C (3): a colorless oil; [α]27D +12 (c 0.073, MeOH); IR (CHCl3) 3689, 3465 (br), 3025, 2953, 
1680, 1603, 1457, 1378, 1227, 1221, 1147, 998, 829 cm–1; 1H and 13C NMR data, see Table 5; HR-ESIMS m/z 
503.2964 [M+Na]+ (calcd for C27H44NaO7, Δ –1.5 mmu). 
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Methods of Calculations. 
   Molecular modeling study using a Merck molecular force field 94x (MMFF94x) was performed by the MOE 
program package (Chemical Computing Group Inc.). Geometry optimization with the density functional theory 
(DFT) method was performed by the Gaussian 09 program package. 12) Ground-state geometry in Figure 30 was 
optimized at the B3LYP/6-31G+ level in the gas phase, and the total energy of individual conformer was obtained. 
This having minimum energy was confirmed by frequency calculation. To calculate ECD spectrum, ground-state 
geometry was optimized at the PBEPBE/6-311G++(d,p) level in implicit solvation mode (CPCM, 7) MeOH), and 
the total energy of individual conformer was obtained. Time-dependent density functional theory (TDDFT) at the 
same level was employed to calculate excitation energy (in nm) and rotatory strength R in dipole velocity (Rvel) 
and dipole length (Rlen) forms. The calculated rotatory strengths were simulated into an ECD curve according to 
the Gaussian 09 program software. Ground-state geometry in Figure 59 was optimized at the B3LYP/6-31G+(d,p) 
level of theory in implicit solvation model (CPCM, 7) CHCl3), and the total energy of individual conformer was 
obtained. This having minimum energy was confirmed by frequency calculation. 
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Cell culture and NO inhibitory assay for murine macrophage cell line RAW264.7. 
   Murine macrophage RAW264.7 cells (ATCC TIB-71) were cultured in Dulbecco’s Modified Eagle’s Medium 
(DMEM) (MP Biomedicals, Solon, Ohis, USA) supplemented with fetal bovine serum (FBS, 10%) and 
L-glutamine in a humidified atmosphere containing CO2 (5%) at 37 °C. For bioassays, aplysiasecosterols were 
stored in DMSO at 10 mM. The NO inhibitory assay was performed by the Griess method according to the 
literature. 1) RAW264.7 cells were seeded at 1 × 105 cells per well in 96-well plates. After incubation overnight at 
37°C, samples (final concentration: 10 and 200 µM) and LPS (final 1 µM, Santa Cruz Biotech, cat. No. sc3535) 
were simultaneously added. After the cells were incubated for 24 h, an aliquot of culture medium (100 µL) was 
mixed with an equal volume of Griess reagent (0.5% sulfamide, 0.05% N-naphthylethylenediamine 
dihydrochloride in 5% phosphoric acid). Absorbance at 540 nm was measured with a TECAN microplate reader 
(Infinite F200 Pro). All assays were performed in duplicate to confirm reproducibility. 
 
Cell culture and cytotoxicity assay for the human cervical carcinoma cell line HeLa S3. 
   A suspension culture-adapted human cervical carcinoma HeLa S3 cells (ATCC CCL-2.2) were cultured in 
Eagle’s minimal essential medium (E-MEM) supplemented with fetal bovine serum (FBS, 10%) in a humidified 
atmosphere containing CO2 (5%) at 37 °C. For bioassays, aplysiasecosterols were stored in DMSO at 10 mM. The 
cytotoxicity assay was performed by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) 
method. HeLa S3 cells were seeded at 2 × 103 cells per well in 96-well plates. After incubation overnight at 37 °C, 
samples (final concentration: 0.2, 2, 20, 200 µM) were added, and the cells were incubated for 96 h at 37 °C. After 
MTT was added, the mixtures were incubated for 4 h to give insoluble formazan derivative from MTT. After 
removal of the medium, the formazan derivative was dissolved with dimethylsulfoxide. Absorbance at 540 nm 
was measured with a TECAN microplate reader (Infinite F200 Pro). The IC50 value (concentration required for 
50% inhibition of cell growth) was determined using a growth curve by comparison of negative control wells. All 
assays were performed in duplicate to confirm reproducibility. 
 
Cell culture and cytotoxicity assay for the human myelomonocytic leukemia cell line HL-60. 
   A human promyelocytic leukemia HL60 cells (JCRB0085 cell line) were cultured in RPMI buffer 
supplemented with fetal bovine serum (FBS, 10 %) and 2 mM L-glutamine in a humidified atmosphere containing 
CO2 (5 %) at 37 °C. For bioassays, aplysiasecosterols were stored in DMSO at 10 mM. HL60 cells were seeded at 
3 × 103 cells per well in 96-well plates. After incubation overnight at 37 °C, samples (final concentration: 0.5, 5, 
50 µM) were added, and the cells were incubated for 72 h at 37 °C. Cell viability was measured by using a Cell 
Counting Kit-8 (DOJINDO) according to the manufacturer’s protocol. Absorbance at 540 nm was measured with 
a TECAN microplate reader (Infinite F200 Pro). The IC50 value (concentration required for 50% inhibition of cell 
growth) was determined using a growth curve by comparison of negative control wells. All assays were 
performed in duplicate to confirm reproducibility. 
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Preparation of 11,24-bis-(S)- and (R)-MTPA esters 8a and 8b from aplysiasecosterol A (1). 
 
 
 
 
11,24-bis-(S)-MTPA ester 8a. 
To a stirred solution of 1 (0.7 mg, 1.5 µmol) in pyridine (50 µL) was added (R)-(+)-MTPACl (2.7 µL, 7.9 µmol). 
The reaction mixture was stirred at room temperature for 16 h, diluted with saturated aqueous NH4Cl (0.2 mL), 
and extracted with ethyl acetate (3 × 2 mL). The combined extracts were washed with brine (2 mL), dried 
(Na2SO4), and concentrated. The residue was purified by reverse-phase HPLC (Develosil ODS-HG-5, Φ20 × 
250 mm, 90% aqueous methanol, 5 mL/min, 254 nm) to afford 11,24-bis-(S)-MTPA ester 8a (0.7 mg, 53%) as a 
colorless oil. 
 
Compuond 8a: 1H NMR (600 MHz, CD3OD) δ 7.59 (m, 2H), 7.48 (m, 2H), 7.44–7.41 (m, 6H), 4.52 (m, 1H), 4.33 
(m, 1H), 3.54 (s, 3H), 3.53 (s, 3H), 3.13 (dd, J = 4.8, 1.9 Hz, 1H), 2.84 (dd, J = 16.3, 6.8 Hz, 1H), 2.82 (br s, 1H), 
2.35 (d, J = 16.3 Hz, 1H), 2.01–1.88 (m, 4H), 1.78–1.26 (m, 14H), 1.12 (s, 3H), 1.08 (s, 3H), 1.04 (s, 3H), 0.97 (d, 
J = 6.6 Hz, 3H), 0.86 (s, 3H); HR-ESIMS m/z 935.3803 [M+Na]+ (calcd for C47H58F6NaO11, Δ +2.2 mmu). 
 
11,24-bis-(R)-MTPA ester 8b. 
A solution of 1 (0.7 mg, 1.5 µmol) in pyridine (50 µL) was similarly treated with (S)-(–)-MTPACl to afford 
11,24-bis-(R)-MTPA ester 8b (0.7 mg, 53%) as a colorless oil. 
 
Compuond 8b: 1H NMR (600 MHz, CD3OD) δ 7.63 (m, 2H), 7.47 (m, 2H), 7.44–7.39 (m, 6H), 4.54 (td, J = 10.9, 
5.31 Hz, 1H), 4.28 (td, J = 10.9, 5.31 Hz, 1H), 3.61 (s, 3H), 3.52 (s, 3H), 3.12 (m, 1H), 2.84 (dd, J = 15.9, 6.8 Hz, 
1H), 2.83 (br s, 1H), 2.37 (d, J = 16.2 Hz, 1H), 2.01–1.88 (m, 3H), 1.79–1.46 (m, 6H), 1.38–1.23 (m, 9H), 1.20 (s, 
3H), 1.17 (s, 3H), 1.11 (m, 1H), 1.04 (s, 3H), 0.83 (d, J = 4.9 Hz, 3H), 0.83 (s, 3H); HR-ESIMS m/z 935.3800 
[M+Na]+ (calcd for C47H58F6NaO11, Δ +1.9 mmu). 
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Figure 66.  1H NMR spectrum of 11,24-(S)-MTPA ester 8a in CD3OD (600 MHz). 
 
 
Figure 67.  COSY spectrum of 11,24-(S)-MTPA ester 8a in CD3OD (600 MHz). 
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Figure 68.  1H NMR spectrum of 11,24-(R)-MTPA ester 8b in CD3OD (600 MHz). 
 
 
Figure 69.  COSY spectrum of 11,24-(R)-MTPA ester 8b in CD3OD (600 MHz).  
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Preparation of 11,24-bis-(S)- and (R)-MTPA esters 10a and 10b from aplysiasecosterol B (2). 
 
 
 
 
11,24-bis-(S)-MTPA ester 10a. 
   To a stirred solution of 2 (0.5 mg, 1.0 µmol) in pyridine (50 µL) was added (R)-(+)-MTPACl (6.8 µL, 20 
µmol) and 4-dimethylaminopyridine (DMAP) (ca. 0.1 mg). The reaction mixture was stirred at room temperature 
for 12 h, diluted with saturated aqueous NH4Cl (0.2 mL), and extracted with ethyl acetate (3 × 2 mL). The 
combined extracts were washed with brine (2 mL), dried (Na2SO4), and concentrated. The residue was purified by 
reverse-phase HPLC (Develosil ODS-HG-5, Φ20 × 250 mm, 90% aqueous methanol, 5 mL/min, 254 nm) to 
afford 3,11,24-tris-(S)-MTPA ester 9a (1.0 mg, 83%). After one week, C-3 MTPA ester of 9a was completely 
hydrolyzed, and was purified again by reverse-phase HPLC (Develosil ODS-HG-5, Φ20 × 250 mm, 90% 
aqueous methanol, 5 mL/min, 254 nm) to afford 11,24-bis-(S)-MTPA ester 10a (0.7 mg, 75%), as a colorless oil.  
 
Compuond 10a: 1H NMR (600 MHz, CD3OD) δ 7.61 (m, 2H), 7.53 (m, 2H), 7.47–7.41 (m, 6H), 6.64 (br s, 1H), 
4.97 (dd, J = 10.3, 1.4 Hz, 1H), 4.48 (m, 2H), 3.98 (m, 1H), 3.51 (s, 6H), 3.45 (dd, J = 10.4, 8.8 Hz, 1H), 1.90–
1.56 (m, 12H), 1.52 (m, 1H), 1.48–1.25 (m, 4H), 1.19 (m, 1H), 1.13 (s, 3H), 1.09 (s, 3H), 1.06 (s, 3H), 0.97 (d, J = 
6.6 Hz, 3H), 0.72 (s, 3H); HR-ESIMS m/z 935.3810 [M+Na]+ (calcd for C47H58F6NaO11, Δ +2.9 mmu). 
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11,24-bis-(R)-MTPA ester 10b. 
A solution of 2 (0.5 mg, 1.0 µmol) in pyridine (50 µL) was similarly treated with (S)-(–)-MTPACl to afford 
11,24-bis-(R)-MTPA ester 10b (0.7 mg, 75%) via tris-(R)-MTPA ester 9b as a colorless oil. 
 
Compuond 10b: 1H NMR (600 MHz, CD3OD) δ 7.65 (m, 2H), 7.50 (m, 2H), 7.45–7.41 (m, 6H), 6.64 (br s, 1H), 
4.98 (dd, J = 10.4, 1.7 Hz, 1H), 4.54 (td, J = 10.3, 5.5 Hz, 1H), 4.33 (td, J = 10.3, 5.5 Hz, 1H), 3.97 (m, 1H), 3.63 
(s, 3H), 3.52 (s, 3H), 3.40 (m, 1H), 1.88–1.62 (m, 10H), 1.62–1.44 (m, 3H), 1.43–1.26 (m, 4H), 1.24 (m, 1H), 
1.21 (s, 3H), 1.18 (s, 3H), 1.05 (s, 3H), 0.81 (d, J = 6.6 Hz, 3H), 0.67 (s, 3H); HR-ESIMS m/z 935.3765 [M+Na]+ 
(calcd for C47H58F6NaO11, Δ –1.6 mmu). 
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Figure 70. 1H NMR spectrum of 11,24-bis-(S)-MTPA ester 10a in CD3OD (600 MHz). 
 
 
Figure 71. COSY spectrum of 11,24-bis-(S)-MTPA ester 10a in CD3OD (600 MHz). 
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Figure 72. 1H NMR spectrum of 11,24-bis-(R)-MTPA ester 10b in CD3OD (600 MHz).  
 
 
Figure 73. COSY spectrum of 11,24-bis-(R)-MTPA ester 10b in CD3OD (600 MHz).  
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Preparation of 11,24-bis-(S)- and (R)-MTPA esters 10c and 10d from aplysiasecosterol C (3). 
 
 
 
 
11,24-bis-(S)-MTPA ester 10c. 
To a stirred solution of 3 (0.2 mg, 0.4 µmol) in pyridine (25 µL) was added (R)-(+)-MTPACl (4.3 µL, 12 µmol) 
and 4-dimethylaminopyridine (DMAP) (ca. 0.1 mg). The reaction mixture was stirred at room temperature for 13 
h, diluted with saturated aqueous NH4Cl (0.2 mL), and extracted with ethyl acetate (3 × 2 mL). The combined 
extracts were washed with brine (2 mL), dried (Na2SO4), and concentrated. The residue was purified by 
reverse-phase HPLC (Develosil ODS-HG-5, Φ20 × 250 mm, 90% aqueous methanol, 5 mL/min, 254 nm) to 
afford 3,11,24-tris-(S)-MTPA ester 9c (0.4 mg, 85%). After one week, C-3 MTPA ester of 9c was completely 
hydrolyzed, and was purified again by reverse-phase HPLC (Develosil ODS-HG-5, Φ20 × 250 mm, 90% 
aqueous methanol, 5 mL/min, 254 nm) to afford 11,24-bis-(S)-MTPA ester 10c (0.3 mg, 78%), as a colorless oil. 
 
Compuond 10c: 1H NMR (600 MHz, CD3OD) δ 7.65 (d, J = 7.6 Hz, 2H), 7.51 (m, 2H), 7.48–7.41 (m, 6H), 6.59 
(br s, 1H), 4.98 (m, 1H), 4.45 (m, 1H), 3.98 (m, 1H), 3.58 (s, 3H), 3.53 (s, 3H), 3.39 (m, 1H), 3.37 (m, 1H), 1.90–
1.79 (m, 4H), 1.79–1.62 (m, 6H), 1.57 (m, 1H), 1.38–1.25 (m, 6H), 1.22 (s, 3H), 1.18 (s, 3H), 1.16 (m, 1H), 1.05 
(s, 3H), 0.93 (d, J = 6.8 Hz, 3H), 0.53 (s, 3H); HR-ESIMS m/z 935.3795 [M+Na]+ (calcd for C47H58F6NaO11, Δ 
+1.4 mmu). 
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11,24-bis-(R)-MTPA ester 10d. 
A solution of 3 (0.2 mg, 0.4 µmol) in pyridine (25 µL) was similarly treated with (S)-(–)-MTPACl to afford 
11,24-bis-(R)-MTPA ester 10d (0.3 mg, 78%) via tris-(R)-MTPA ester 9d as a colorless oil. 
 
Compuond 10d: 1H NMR (600 MHz, CD3OD) δ 7.59 (m, 2H), 7.49 (m, 2H), 7.46–7.40 (m, 6H), 6.61 (br s, 1H), 
4.95 (m, 1H), 4.53 (td, J = 10.7, 5.3 Hz, 1H), 4.40 (td, J = 10.7, 5.3 Hz, 1H), 3.97 (m, 1H), 3.54 (s, 3H), 3.52 (s, 
3H), 3.41 (m, 1H), 1.96 (m, 1H), 1.89–1.76 (m, 5H), 1.76–1.64 (m, 6H), 1.52 (m, 1H), 1.48– 1.36 (m, 3H), 1.26 
(m, 1H), 1.14 (s, 3H), 1.09 (s, 3H), 1.08 (m, 1H), 1.07 (s, 3H), 0.98 (d, J = 6.7 Hz, 3H), 0.68 (s, 3H); HR-ESIMS 
m/z 935.3756 [M+Na]+ (calcd for C47H58F6NaO11, Δ –2.5 mmu). 
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Figure 74. 1H NMR spectrum of 11,24-bis-(S)-MTPA ester 10c in CD3OD (600 MHz).  
 
 
Figure 75. COSY spectrum of 11,24-bis-(S)-MTPA ester 10c in CD3OD (600 MHz).  
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Figure 76. 1H NMR spectrum of 11,24-bis-(R)-MTPA ester 10d in CD3OD (600 MHz). 
 
 
Figure 77. COSY spectrum of 11,24-bis-(R)-MTPA ester 10d in CD3OD (600 MHz).  
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Acetonide 11 from 11,24-bis-(S)-MTPA ester 10a. 
 
 
 
To a stirred solution of 10a (0.30 mg, 0.32 µmol) in dry 1,2-dichroloethane (50 µL) under a nitrogen atmosphere 
were added PPTS (ca. 0.1 mg) and 2-methoxypropene (5 µL, 50 µmol). The reaction mixture was stirred at room 
temperature for 24 h and concentrated in vacuo. The residue was directly analyzed by reverse-phase HPLC 
(Develosil ODS-HG-5, Φ4.6 × 250 mm, 88% MeOH aq. 1 mL /min, 254 nm, 25 °C) to detect acetonide 11 (ca. 
10 µg, ~3%, estimated based on the UV absorbance, see Figure 78) and recovered 10a (~10 µg, tR 3.6 min). 
 
Compound 11: LC-MS (ESI, positive) m/z 975.5 [M+H]+ (Develosil ODS-HG-5, Φ1.5 × 150 mm, 88% MeOH 
aq., 0.1 mL/min, tR 7.0 min); HR-ESIMS m/z 975.4075 [M+Na]+ (calcd for C50H62F6NaO11, Δ –1.9 mmu). 
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Figure 78. LC-MS detection of acetonide 11. (a) HPLC chromatogram of the reaction mixture containing 
acetonide 11 (solid bar). Detection: UV 254 nm. (b) ESI-MS chromatogram. Column, Develosil ODS-HG-5 (Φ
1.5 × 150 mm); elution, 88% MeOH aq.; flow rate, 0.1 mL/min; temp., 25 °C. Compounds 11 (m/z 975.5, tR 7.0 
min) and the starting material 10a (m/z 935.5, tR 3.6 min) were detected as single peaks, respectively. (c) Mass 
spectrum of 11 obtained by LC-MS analysis. 
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Chapter 3. Conclusion 
 
3-1. Conclusion 
 
   In the chemotherapy, a variety of natural products and their derivatives are used as drugs now. These drugs 
include the secondary metabolites. Especially, marine organisms produce various secondary metabolites that have 
unique chemical structures and potent bioactivities. The author has searched the sea hare Aplysia kurodai for the 
novel compounds exhibiting NO production inhibitory activity and other bioactive substances. 
The separation of the extract of A. kurodai guided by the NO production inhibitory assay with LPS-stimulated 
murine macrophage RAW264.7 cells, afforded a active fraction. From this fraction, three novel 9,11-secosteroids, 
aplysiasecosterols A, B, and C (1, 2, and 3), were isolated. The author completely determined the stereo-structures 
of 1, 2, and 3. While, compound 1 had a cyclopentane ring and a side-chain part of 9,11-secosteroidal skeleton, 
possessed an unprecedented tricyclic γ-diketone structure instead of AB-rings. Compounds 2 and 3 had 
9,11-secosteroidal skeleton with a cis-fused conjugated 1,4-diketone structure. 
   Compounds 1 and 2 were isolated from the same marine organism, and the structure of the D-ring and the 
side-chain part of 9,11-secosteroid 2 was identical to those of 1. Therefore, the author presumed that 2 is a 
biosynthetic precursor of 1. Then, the author proposed a biosynthetic pathway for the tricyclic γ-diketone structure 
of 1 starting from 2, which includes twice α-ketol-type rearrangements and an intramolecular acetalization.  
   While 2 and 3 showed no cytotoxicity showed moderate cytotoxicity (IC50 >200 µM), 1 exhibited moderate 
cytotoxicity against HL-60 cells (IC50 16 µM). 
   Compounds 1, 2, and 3 did not exhibit significant NO production inhibitory activity at 100 µM. After the 
isolation of these compounds, the author investigated the NO production inhibitory activity of other remaining 
fractions. As a result, two fractions exhibited the NO production inhibitory activity. Therefore, it seems that these 
fractions might contain compounds to inhibit NO production in RAW264.7 cells. 
 
 
 
 
 
 
 
 
 
 
 
 89 
 
 
 
 
Figure 79. Structures of aplysiasecosterols A, B, and C form the sea hare Aplysia kurodai. 
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